vs
Idexx Laboratories（IDXX）与RANGE RESOURCES CORP（RRC）财务数据对比。点击上方公司名可切换其他公司
Idexx Laboratories的季度营收约是RANGE RESOURCES CORP的1.4倍（$1.1B vs $786.9M），RANGE RESOURCES CORP净利率更高（22.8% vs 22.8%，领先0.0%），RANGE RESOURCES CORP同比增速更快（18.0% vs 14.3%），过去两年RANGE RESOURCES CORP的营收复合增速更高（14.6% vs 6.4%）
IDEXX Laboratories是1983年成立的美国跨国企业，主营伴侣动物诊疗、畜禽养殖、水质检测、乳制品领域相关产品与服务的研发、生产及分销，总部位于缅因州韦斯特布鲁克，欧洲、中东及非洲地区分部设于荷兰霍夫多普。
Range Resources Corporation是一家总部位于美国得克萨斯州沃斯堡的天然气勘探开采企业，核心运营区域为马塞勒斯页岩地层，是该地区拥有土地面积最大的运营商，专注于天然气资源的勘探、开发与生产业务，在北美油气开发领域具备深厚的行业积累。
IDXX vs RRC — 直观对比
营收规模更大
IDXX
是对方的1.4倍
$786.9M
营收增速更快
RRC
高出3.7%
14.3%
净利率更高
RRC
高出0.0%
22.8%
两年增速更快
RRC
近两年复合增速
6.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $786.9M |
| 净利润 | $248.2M | $179.1M |
| 毛利率 | 60.3% | 94.5% |
| 营业利润率 | 28.9% | — |
| 净利率 | 22.8% | 22.8% |
| 营收同比 | 14.3% | 18.0% |
| 净利润同比 | 14.8% | 88.8% |
| 每股收益（稀释后） | $3.09 | $0.75 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IDXXRRC
| Q4 25 | $1.1B | $786.9M | ||
| Q3 25 | $1.1B | $655.3M | ||
| Q2 25 | $1.1B | $699.6M | ||
| Q1 25 | $998.4M | $846.3M | ||
| Q4 24 | $954.3M | $667.0M | ||
| Q3 24 | $975.5M | $567.9M | ||
| Q2 24 | $1.0B | $513.2M | ||
| Q1 24 | $964.1M | $598.8M |
净利润IDXXRRC
| Q4 25 | $248.2M | $179.1M | ||
| Q3 25 | $274.6M | $144.3M | ||
| Q2 25 | $294.0M | $237.6M | ||
| Q1 25 | $242.7M | $97.1M | ||
| Q4 24 | $216.1M | $94.8M | ||
| Q3 24 | $232.8M | $50.7M | ||
| Q2 24 | $203.3M | $28.7M | ||
| Q1 24 | $235.6M | $92.1M |
毛利率IDXXRRC
| Q4 25 | 60.3% | 94.5% | ||
| Q3 25 | 61.8% | 92.5% | ||
| Q2 25 | 62.6% | 95.0% | ||
| Q1 25 | 62.4% | 93.1% | ||
| Q4 24 | 59.8% | 93.7% | ||
| Q3 24 | 61.1% | 94.3% | ||
| Q2 24 | 61.7% | 93.4% | ||
| Q1 24 | 61.5% | 94.7% |
营业利润率IDXXRRC
| Q4 25 | 28.9% | — | ||
| Q3 25 | 32.1% | — | ||
| Q2 25 | 33.6% | — | ||
| Q1 25 | 31.7% | — | ||
| Q4 24 | 27.4% | — | ||
| Q3 24 | 31.2% | — | ||
| Q2 24 | 26.3% | — | ||
| Q1 24 | 31.0% | — |
净利率IDXXRRC
| Q4 25 | 22.8% | 22.8% | ||
| Q3 25 | 24.8% | 22.0% | ||
| Q2 25 | 26.5% | 34.0% | ||
| Q1 25 | 24.3% | 11.5% | ||
| Q4 24 | 22.7% | 14.2% | ||
| Q3 24 | 23.9% | 8.9% | ||
| Q2 24 | 20.3% | 5.6% | ||
| Q1 24 | 24.4% | 15.4% |
每股收益（稀释后）IDXXRRC
| Q4 25 | $3.09 | $0.75 | ||
| Q3 25 | $3.40 | $0.60 | ||
| Q2 25 | $3.63 | $0.99 | ||
| Q1 25 | $2.96 | $0.40 | ||
| Q4 24 | $2.62 | $0.38 | ||
| Q3 24 | $2.80 | $0.21 | ||
| Q2 24 | $2.44 | $0.12 | ||
| Q1 24 | $2.81 | $0.38 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $180.1M | $204.0K |
| 总债务越低越好 | $450.0M | $1.2B |
| 股东权益账面价值 | $1.6B | $4.3B |
| 总资产 | $3.4B | $7.4B |
| 负债/权益比越低杠杆越低 | 0.28× | 0.28× |
8季度趋势，按日历期对齐
现金及短期投资IDXXRRC
| Q4 25 | $180.1M | $204.0K | ||
| Q3 25 | $208.2M | $175.0K | ||
| Q2 25 | $164.6M | $134.0K | ||
| Q1 25 | $164.0M | $344.6M | ||
| Q4 24 | $288.3M | $304.5M | ||
| Q3 24 | $308.6M | $277.4M | ||
| Q2 24 | $401.6M | $251.1M | ||
| Q1 24 | $397.4M | $343.1M |
总债务IDXXRRC
| Q4 25 | $450.0M | $1.2B | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $1.7B | ||
| Q4 24 | $617.8M | $1.7B | ||
| Q3 24 | — | $1.7B | ||
| Q2 24 | — | $1.7B | ||
| Q1 24 | — | $1.8B |
股东权益IDXXRRC
| Q4 25 | $1.6B | $4.3B | ||
| Q3 25 | $1.6B | $4.2B | ||
| Q2 25 | $1.5B | $4.1B | ||
| Q1 25 | $1.4B | $3.9B | ||
| Q4 24 | $1.6B | $3.9B | ||
| Q3 24 | $1.6B | $3.9B | ||
| Q2 24 | $1.6B | $3.9B | ||
| Q1 24 | $1.6B | $3.8B |
总资产IDXXRRC
| Q4 25 | $3.4B | $7.4B | ||
| Q3 25 | $3.4B | $7.2B | ||
| Q2 25 | $3.3B | $7.1B | ||
| Q1 25 | $3.2B | $7.4B | ||
| Q4 24 | $3.3B | $7.3B | ||
| Q3 24 | $3.4B | $7.2B | ||
| Q2 24 | $3.4B | $7.3B | ||
| Q1 24 | $3.4B | $7.4B |
负债/权益比IDXXRRC
| Q4 25 | 0.28× | 0.28× | ||
| Q3 25 | — | 0.29× | ||
| Q2 25 | — | 0.29× | ||
| Q1 25 | — | 0.43× | ||
| Q4 24 | 0.39× | 0.43× | ||
| Q3 24 | — | 0.44× | ||
| Q2 24 | — | 0.44× | ||
| Q1 24 | — | 0.46× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $355.8M | $257.5M |
| 自由现金流经营现金流 - 资本支出 | $326.3M | — |
| 自由现金流率自由现金流/营收 | 29.9% | — |
| 资本支出强度资本支出/营收 | 2.7% | — |
| 现金转化率经营现金流/净利润 | 1.43× | 1.44× |
| 过去12个月自由现金流最近4个季度 | $1.1B | — |
8季度趋势，按日历期对齐
经营现金流IDXXRRC
| Q4 25 | $355.8M | $257.5M | ||
| Q3 25 | $402.3M | $247.5M | ||
| Q2 25 | $185.7M | $336.2M | ||
| Q1 25 | $238.0M | $330.1M | ||
| Q4 24 | $262.0M | $217.9M | ||
| Q3 24 | $220.1M | $245.9M | ||
| Q2 24 | $248.3M | $148.8M | ||
| Q1 24 | $198.6M | $331.9M |
自由现金流IDXXRRC
| Q4 25 | $326.3M | — | ||
| Q3 25 | $371.2M | — | ||
| Q2 25 | $151.6M | — | ||
| Q1 25 | $207.9M | — | ||
| Q4 24 | $232.8M | — | ||
| Q3 24 | $192.0M | — | ||
| Q2 24 | $215.0M | — | ||
| Q1 24 | $168.3M | — |
自由现金流率IDXXRRC
| Q4 25 | 29.9% | — | ||
| Q3 25 | 33.6% | — | ||
| Q2 25 | 13.7% | — | ||
| Q1 25 | 20.8% | — | ||
| Q4 24 | 24.4% | — | ||
| Q3 24 | 19.7% | — | ||
| Q2 24 | 21.4% | — | ||
| Q1 24 | 17.5% | — |
资本支出强度IDXXRRC
| Q4 25 | 2.7% | — | ||
| Q3 25 | 2.8% | — | ||
| Q2 25 | 3.1% | — | ||
| Q1 25 | 3.0% | — | ||
| Q4 24 | 3.1% | — | ||
| Q3 24 | 2.9% | — | ||
| Q2 24 | 3.3% | — | ||
| Q1 24 | 3.1% | — |
现金转化率IDXXRRC
| Q4 25 | 1.43× | 1.44× | ||
| Q3 25 | 1.47× | 1.72× | ||
| Q2 25 | 0.63× | 1.42× | ||
| Q1 25 | 0.98× | 3.40× | ||
| Q4 24 | 1.21× | 2.30× | ||
| Q3 24 | 0.95× | 4.85× | ||
| Q2 24 | 1.22× | 5.18× | ||
| Q1 24 | 0.84× | 3.60× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IDXX
| Vet Lab Consumables | $389.0M | 36% |
| Reference Laboratory Diagnostic And Consulting Services | $349.2M | 32% |
| Rapid Assay Products | $76.0M | 7% |
| Recurring Revenue | $70.6M | 6% |
| CAG Diagnostic Capital Instruments | $58.1M | 5% |
| Water Segment | $50.5M | 5% |
| Livestock And Poultry Diagnostics Segment | $37.5M | 3% |
| CAG Diagnostics Service And Accessories | $35.3M | 3% |
| Systems And Hardware | $20.1M | 2% |
| Rebate And Up Front Considerations Arrangements | $2.4M | 0% |
| Extended Warranties And Post Contract Support Revenue | $1.0M | 0% |
RRC
| Natural Gas Natural Gas Liquids And Oil Sales | $745.5M | 95% |
| Brokered Natural Gas And Marketing | $41.3M | 5% |
